November 07, 2012
1172012Xeljanz Approved for Rheumatoid ArthritisXeljanz (tofacitinib) has
been approved by the U.S. Food and Drug Administration to treat
symptoms of rheumatoid arthritis (RA) among people who can't
tolerate, or haven't been helped by, the drug methotrexate.